Cowen analyst Vivien Azer was the latest to weight in on surprise news from the FDA that that it intends ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

British American Tobacco (BTI) Outlook Remains Positive at UBS Despite FDA UncertaintyAugust 1, 2017 6:03 AM SBG Securities Upgrades British American Tobacco (BTI) to BuyJuly 31, 2017 6:46 AM RBC Capital Upgrades Altria (MO) to Sector PerformJuly 31, 2017 4:35 AM Stifel Says FDA News is a Negative for Tobacco Stocks; Altria (MO) Best Positioned, and Philip Morris (PM) Has Lack of U.S. ExposureJuly 28, 2017 11:25 AM Altria Group (MO) Defended at Wells FargoJuly 28, 2017 11:20 AM Philip Morris (PM) Defended at Piper JaffrayJuly 28, 2017 11:03 AM Cowen, Jefferies React To Tobacco Name SelloffJuly 28, 2017 10:59 AM Tobacco Stocks Off Lows on Analyst DefenseJuly 28, 2017 10:51 AM Altria (MO), British American Tobacco (BTI) Shares Crushed Following FDA Announcement Discussing Lower Nicotine Levels in CigarettesJuly 28, 2017 10:31 AM FDA to Begin Public Dialogue about Lowering Nicotine Levels in Combustible Cigarettes to Non-addictive LevelsJuly 28, 2017 10:03 AM